| Dr Vaseem Moulana, MD | |
|
1240 Woodland Dr, Elizabethtown, KY 42701-2767 | |
| (270) 769-9881 | |
| (270) 769-9589 |
| Full Name | Dr Vaseem Moulana |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 1240 Woodland Dr, Elizabethtown, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316959968 | NPI | - | NPPES |
| 64317795 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 31779 (Kentucky) | Primary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | 31779 (Kentucky) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vaseem Moulana, MD 1240 Woodland Dr, Elizabethtown, KY 42701-2767 Ph: (270) 769-9881 | Dr Vaseem Moulana, MD 1240 Woodland Dr, Elizabethtown, KY 42701-2767 Ph: (270) 769-9881 |
News Archive
In this Atlantic opinion piece, Amanda Glassman, director of Global Health Policy at the Center for Global Development (CGD), reports on how lengthy, inefficient review processes for drug and vaccine candidates waiting in the pipeline for late stages of clinical development is keeping promising new medicines, vaccines, and diagnostic techniques from reaching millions in need.
The Endocrine Society warned that the President's proposal to slash $7.16 billion, or more than a fifth, of the National Institutes of Health's budget, and $1.2 billion from the Centers for Disease Control and Prevention would hinder progress toward needed medical treatments and advances in public health and disease prevention.
Eurand has announced that Eurand Pharmaceuticals Ltd. initiated the rolling submission of its new drug application (NDA) with the U.S. Food and Drug Administration (FDA) for Zentase for the treatment of Exocrine Pancreatic Insufficiency (EPI). Zentase (formerly EUR-1008), the company's lead product candidate, has been granted fast-track designation by the FDA.
Valeant Pharmaceuticals International announced today that it has priced its previously announced offering of senior unsecured notes, which consists of $500 million of 6.75% Senior Notes due 2017 and $700 million of 7.00% Senior Notes due 2020 (collectively, the "Notes"). The $1.2 billion combined aggregate principal amount of the Notes was increased from the previously announced offering size of $1.0 billion. The offering is expected to close on or about September 28, 2010.
› Verified 5 days ago
John A Godfrey, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 914 N Dixie Ave, Ste 304, Elizabethtown, KY 42701 Phone: 270-769-1049 Fax: 270-735-1978 | |
Dr. Charles Kenny Maffet, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 105 Diecks Dr, Elizabethtown, KY 42701 Phone: 270-737-6300 | |
Mallory Ann Doyle, AGPCNP Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 105 Financial Pl, Elizabethtown, KY 42701 Phone: 270-765-5112 | |
Mahendra M Patel, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 105 Financial Pl Ste 105, Elizabethtown, KY 42701 Phone: 270-765-5112 Fax: 270-737-9252 | |
Dr. Scott Raymond Monnin, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1324 Woodland Dr Ste A, Elizabethtown, KY 42701 Phone: 270-765-5921 Fax: 270-982-3324 | |
Mrs. Vivian H Bland, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 914 N Dixie Ave, Suite 306, Elizabethtown, KY 42701 Phone: 270-769-1559 Fax: 270-234-9152 | |
Dr. Kamal Moulana, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1240 Woodland Dr, Elizabethtown, KY 42701 Phone: 270-769-9881 Fax: 270-769-9589 |